BioXcel Therapeutics (BX20.F) Q1 2025 Earnings

27MarConfirmed
Q4 2024
Q1 2025
-7.68
-6.22
-4.76
-3.31

Details

Expected EPS
-5.59583991712
Actual EPS
-3.3052487999999998
Surprise EPS
2.29
Surprise Percent
+40.93%

Description

BioXcel Therapeutics (BX20.F) has reported earnings of -3.3052487999999998 per share for Q1 2025.

0 Comments

Share your thoughts